title: Histological and urinary reactivity of monoclonal antibody 1BE12 in bladder carcinoma. Purification of the antigen from urine.
abstract: We have previously reported the production of monoclonal antibody (MAb) 1BE12, which recognizes a glycoprotein in breast-cancer cells. In the present work, 1BE12 reactivity was tested by immunohistochemistry in bladder carcinoma (92 cases) and in non-tumoral bladder samples (15 cases). In 71% of bladder tumors, more than 30% of cells were intensely stained by 1BE12. The percentage of reactive cells was higher in cancers invading the muscle than in more superficial tumors (p = 0.039). In non-tumoral bladder, immuno-staining, when present, was usually confined to the superficial layers with a low number of cells stained (less than 30%) in 13/15 cases. Slot blots, performed on urine samples from 43 bladder-cancer patients and 21 healthy controls, were quantified by densitometry scanning. We found higher optical density (OD) values in urine from muscle-invasive-cancer patients than in urine from more superficial tumors and healthy controls, with a significantly different distribution (p = 0.005). The urinary antigen was detected by immunoblotting with 1BE12 as high-molecular-weight species (greater than 150 kDa). The reactive glycoprotein could thus be purified by immunoaffinity and FPLC filtration from the perchloric-acid-soluble fraction of urine from patients with invasive bladder carcinoma. The availability of purified antigen will allow us to quantitate our assay, in order to evaluate its potential use as a prognostic indicator in bladder-cancer patients.
authors.affiliation: CNRS-URA, Unité 523, DICA, University of Technology, Compiègne, France.
authors.forename: G
authors.initials: G
authors.lastname: Pancino
authors.forename: M E
authors.initials: ME
authors.lastname: Toubert
authors.forename: E
authors.initials: E
authors.lastname: Osinaga
authors.forename: F
authors.initials: F
authors.lastname: Chatelet
authors.forename: M
authors.initials: M
authors.lastname: Leroy
authors.forename: M H
authors.initials: MH
authors.lastname: Schlageter
authors.forename: F
authors.initials: F
authors.lastname: Desroys du Roure
authors.forename: F
authors.initials: F
authors.lastname: Calvo
authors.forename: P
authors.initials: P
authors.lastname: Teillac
authors.forename: Y
authors.initials: Y
authors.lastname: Najean
mesh_terms: D000911:Antibodies, Monoclonal / Q000276:immunology; D000951:Antigens, Neoplasm / Q000032:analysis / Q000276:immunology / Q000652:urine*; D004848:Epithelium / Q000276:immunology; D006801:Humans; D015151:Immunoblotting; D007124:Immunoenzyme Techniques; D008970:Molecular Weight; D001743:Urinary Bladder / Q000276:immunology; D001749:Urinary Bladder Neoplasms / Q000276:immunology* / Q000652:urine
chemical_list: D000911:Antibodies, Monoclonal; D000951:Antigens, Neoplasm